Torsten Hombeck
Equibles does not estimate personal net worth.
Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.
Get AKTX alertsAbout Torsten Hombeck
Torsten Hombeck is recorded as CFO at Akari Therapeutics Plc (AKTX) since December 16, 2024. Akari Therapeutics Plc reported in an 8-K filed August 29, 2025 that Torsten Hombeck resigned as Chief Financial Officer, effective October 10, 2025. Akari Therapeutics Plc reported in an 8-K filed December 16, 2024 that Torsten Hombeck was appointed Chief Financial Officer, effective December 16, 2024. The proxy statement of Akari Therapeutics Plc reports total compensation of $621,955 for Torsten Hombeck in fiscal 2025, including a base salary of $234,091. Disclosed compensation is on record for 4 fiscal years. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Abizer Gaslightwala (CEO and Board Member), Samir R. Patel (CEO), Samir R. Patel, M.D. (CEO) and 6 others.
“On August 28, 2025, Torsten Hombeck, Chief Financial Officer of the Company, notified the Company of his decision to resign to be effective October 10, 2025.”
“On December 12, 2024, the board of directors of the Company (the “Board”) approved the appointment of Torsten Hombeck to Chief Financial Officer, effective December 16, 2024.”
Affiliation history
-
Current
2024-12-16–present
-
2024-12-16–2025-10-10
-
Start not stated–2025-10-10
Company network
Leadership on record at Akari Therapeutics Plc
- Abizer Gaslightwala CEO, Board Member
- Samir R. Patel CEO
- Samir R. Patel, M.D. CEO
- Hoyoung Huh Chairman, Board Member
- Kameel Farag CFO
- Samir Patel CFO
- James Neal Board Member
- Robert Bazemore Board Member
- Sandip Patel Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akari Therapeutics Plc (AKTX) | Former Interim Chief Financial Officer | $234,091 | $621,955 |
| 2024 | Akari Therapeutics Plc (AKTX) | Former Interim Chief Financial Officer | $12,500 | $12,500 |
| 2023 | Akari Therapeutics Plc (AKTX) | Chief Financial Officer | $138,945 | $167,506 |
| 2022 | Akari Therapeutics Plc (AKTX) | Former Chief Financial Officer | $300,150 | $448,745 |